Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?

Despite several clinical trials have assessed different agents in the adjuvant setting, renal cell carcinoma (RCC) still remains a disease orphan of an effective adjuvant treatment. In fact, systemic therapies targeting angiogenesis that have been observed to be effective in metastatic setting faile...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Androl Urol
Hlavní autoři: Mollica, Veronica, Rizzo, Alessandro, Di Nunno, Vincenzo, Santoni, Matteo, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Cimadamore, Alessia, Montironi, Rodolfo, Massari, Francesco
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
Review Article on Update on Molecular Classification and Individualized Treatments of Genitourinary Tumors
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039625/
https://ncbi.nlm.nih.gov/pubmed/33850792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1125
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky